Randa Bascharon, DO
Orthopaedic Surgery · Las Vegas, NVNPI 1205883642
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 52.7% of the total. 2025 is the largest year on record at $3,606, 2.6 times the $1,375 reported in 2019.
Across 98 payments — averaging $97.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Goode Surgical Inc$3K
- Pacira Pharmaceuticals Incorporated$463
- Stryker$329
- Smith+Nephew$270
- Orthofix Medical, Inc.$211
- plus $586 from 8 others
What the payments were for
- Travel & lodging$3,00931%
- Food & beverage$4,79750%
- Education$1,76118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 57 | $5,043 |
| Goode Surgical Inc | 13 | $2,664 |
| Pacira Pharmaceuticals Incorporated | 3 | $463 |
| Stryker | 6 | $329 |
| Smith+Nephew | 8 | $270 |
| Orthofix Medical, Inc. | 2 | $211 |
| Miach Orthopaedics, Inc. | 1 | $163 |
| Organogenesis Inc. | 1 | $133 |
| Vericel Corporation | 1 | $105 |
| KCI USA, Inc. | 1 | $100 |
| Johnson & Johnson | 2 | $40 |
| DJO, LLC | 1 | $28 |
| Boston Scientific | 1 | $12 |
| Maxx Orthopedics, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,567 in reported general payments places this provider in the 60th percentile of 135 orthopaedic surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 12 | $22,735 |
| ZilrettaTriamcinolone Acetonide | 12 | $11,197 |
| Diclofenac Sodium | 74 | $5,766 |
| Celecoxib | 85 | $2,866 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $2,468 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 74 | $2,437 |
| Oxycodone Hcl | 23 | $988 |
| Ibuprofen | 65 | $483 |
| Methylprednisolone | 62 | $352 |
| Cyclobenzaprine Hcl | 15 | $265 |
| Tramadol Hcl | 52 | $231 |
| Gabapentin | 12 | $80 |
| Carisoprodol | 13 | $67 |
| Meloxicam | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Pacira Pharmaceuticals IncorporatedZilretta | $463 | $11,19712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 135 orthopaedic surgery providers in Nevada.
Other orthopaedic surgery in Las Vegas
- Mark BarryLas Vegas$9.5M
- Erik KubiakLas Vegas$7.8M
- Russell NevinsLas Vegas$1.5M
- Vladimir SinkovLas Vegas$434K
- Ronald HillockLas Vegas$275K
- Galen KamLas Vegas$270K
- Michael DaubsLas Vegas$215K
- John BaldaufLas Vegas$117K
- Brian CarrLas Vegas$91K
- Brandon RomeroLas Vegas$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.